Kathryn Dawson, MD
Interventional Cardiology · Portland, ORNPI 1477997724
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (41.3%), grants and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Abbott at 49.8% of the total. 2025 is the largest year on record at $30,981, more than ten times the $100 reported in 2019.
Across 160 payments — averaging $355.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$28K
- Boston Scientific$22K
- Medtronic$3K
- Asahi Intecc USA, Inc.$1K
- Teleflex LLC$1K
- Shockwave Medical, Inc$713
- plus $1K from 7 others
What the payments were for
- Consulting fees$23,50041%
- Grants$20,00035%
- Travel & lodging$5,69110%
- Food & beverage$7,75214%
- Education$60%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 29 | $28,347 |
| Boston Scientific | 26 | $21,846 |
| Medtronic | 34 | $2,578 |
| Asahi Intecc USA, Inc. | 37 | $1,274 |
| Teleflex LLC | 10 | $1,074 |
| Shockwave Medical, Inc | 6 | $713 |
| Abiomed | 12 | $655 |
| Arrow International, Inc. | 1 | $173 |
| Biotronik Inc. | 1 | $118 |
| Reflow Medical Inc | 1 | $81 |
| Edwards Lifesciences | 1 | $49 |
| BD | 1 | $22 |
| Johnson & Johnson | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIS$27,705
- GENERAL ATHERECTOMY$20,000
- RESOLUTE ONYX$1,352
- AVVIGO Guidance System$791
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$697
- GUIDELINER$442
- MANTA$413
- TURNPIKE$266
- PERIPHERAL VASCULAR$250
- Asahi Coronary Wires$146
- COREVALVE EVOLUT R$136
- Asahi Peripheral Vascular Wires$128
- Impella$124
- STINGRAY$107
- SYNERGY$100
How this compares
$56,950 in reported general payments places this provider in the 85th percentile of 68 interventional cardiology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 34 | $545 |
| ClopidogrelClopidogrel Bisulfate | 56 | $274 |
| Metoprolol Succinate | 25 | $227 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 21 | $197 |
| Rosuvastatin Calcium | 11 | $116 |
| Losartan Potassium | 18 | $102 |
| Amlodipine Besylate | 12 | $60 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Portland
- Jason WollmuthPortland$749K
- Ethan KorngoldPortland$407K
- Amish DesaiPortland$186K
- Harsh GolwalaPortland$105K
- Brandon JonesPortland$101K
- Logan VincentPortland$42K
- Amged AbdelazizPortland$38K
- Richard SohnPortland$38K
- Daniel FeldmanPortland$36K
- Kris KumarPortland$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.